Related Experiment Videos
Bronchial hyperreactivity revisited
1Allergy Clinical Immunology Service, Walter Reed Army Medical Center, Washington, DC, USA.
Summary
Bronchial reactivity is not a straightforward diagnostic for asthma or a reliable measure of its severity. Its relationship to lung diseases and symptom production requires further investigation.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Clinical Immunology
Background:
- Bronchial reactivity, a measure of airway responsiveness, is a key feature in several respiratory conditions.
- Its precise role in the pathogenesis and clinical course of diseases like asthma remains incompletely understood.
Purpose of the Study:
- To review the detection methods for bronchial reactivity.
- To explore its clinical and pathological correlates.
- To assess its utility as a diagnostic marker for asthma and a measure of disease severity and treatment response.
Main Methods:
- Systematic review of English-language medical literature on bronchial hyperreactivity in human subjects.
- Analysis of studies correlating inflammation markers (bronchoalveolar lavage, biopsy) with bronchial hyperresponsiveness.
- Inclusion of studies on inhaled corticosteroid treatments in mild to moderate asthma.
Main Results:
- Bronchial hyperreactivity is not consistently linked to inflammation and can occur independently of it.
- Its diagnostic sensitivity and specificity for asthma are less certain than previously believed.
- Bronchial reactivity does not appear to strongly correlate with asthma severity or treatment response.
Conclusions:
- Airway hyperresponsiveness is observed in various conditions, but its link to symptom generation and clinical outcomes is unclear.
- Further research is necessary to clarify the complex relationships between airway hyperreactivity, asthma, other lung diseases, and the factors influencing its development.